skip to main content


The NSF Public Access Repository (NSF-PAR) system and access will be unavailable from 5:00 PM ET until 11:00 PM ET on Friday, June 21 due to maintenance. We apologize for the inconvenience.

Search for: All records

Creators/Authors contains: "Wang, Ruigang"

Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

  1. Free, publicly-accessible full text available January 1, 2025
  2. Free, publicly-accessible full text available January 1, 2025
  3. Free, publicly-accessible full text available September 27, 2024
  4. In this report, CeO 2 and SiO 2 supported 1 wt% Ru catalysts were synthesized and studied for dry reforming of methane (DRM) by introducing non-thermal plasma (NTP) in a dielectric barrier discharge (DBD) fixed bed reactor. From quadrupole mass spectrometer (QMS) data, it is found that introducing non-thermal plasma in thermo-catalytic DRM promotes higher CH 4 and CO 2 conversion and syngas (CO + H 2 ) yield than those under thermal catalysis only conditions. According to the H 2 -TPR, CO 2 -TPD, and CO-TPD profiles, reducible CeO 2 supported Ru catalysts presented better activity compared to their irreducible SiO 2 supported Ru counterparts. For instance, the molar concentrations of CO and H 2 were 16% and 9%, respectively, for plasma-assisted thermo-catalytic DRM at 350 °C, while no apparent conversion was observed at the same temperature for thermo-catalytic DRM. Highly energetic electrons, ions, and radicals under non-equilibrium and non-thermal plasma conditions are considered to contribute to the activation of strong C–H bonds in CH 4 and C–O bonds in CO 2 , which significantly improves the CH 4 /CO 2 conversion during DRM reaction at low temperatures. At 450 °C, the 1 wt% Ru/CeO 2 nanorods sample showed the highest catalytic activity with 51% CH 4 and 37% CO 2 conversion compared to 1 wt% Ru/CeO 2 nanocubes (40% CH 4 and 30% CO 2 ). These results clearly indicate that the support shape and reducibility affect the plasma-assisted DRM reaction. This enhanced DRM activity is ascribed to the surface chemistry and defect structures of the CeO 2 nanorods support that can provide active surface facets, higher amounts of mobile oxygen and oxygen vacancy, and other surface defects. 
    more » « less
  5. Abstract The coronavirus disease 2019 (COVID-19) is a highly contagious and fatal disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In general, the diagnostic tests for COVID-19 are based on the detection of nucleic acid, antibodies, and protein. Among different analytes, the gold standard of the COVID-19 test is the viral nucleic acid detection performed by the quantitative reverse transcription polymerase chain reaction (qRT-PCR) method. However, the gold standard test is time-consuming and requires expensive instrumentation, as well as trained personnel. Herein, we report an ultrasensitive electrochemical biosensor based on zinc sulfide/graphene (ZnS/graphene) nanocomposite for rapid and direct nucleic acid detection of SARS-CoV-2. We demonstrated a simple one-step route for manufacturing ZnS/graphene by employing an ultrafast (90 s) microwave-based non-equilibrium heating approach. The biosensor assay involves the hybridization of target DNA or RNA samples with probes that are immersed into a redox active electrolyte, which are detectable by electrochemical measurements. In this study, we have performed the tests for synthetic DNA samples and, SARS-CoV-2 standard samples. Experimental results revealed that the proposed biosensor could detect low concentrations of all different SARS-CoV-2 samples, using such as S, ORF 1a, and ORF 1b gene sequences as targets. This microwave-synthesized ZnS/graphene-based biosensor could be reliably used as an on-site, real-time, and rapid diagnostic test for COVID-19. 
    more » « less